What's new? Log in Free sign up

Filing search / Oncorus, Inc. / "Healthcare"

Search information

Oncorus, Inc.

Companies

"Healthcare"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

39 results

Newest first Best match first

ONCR Oncorus, Inc.

Annual report (amended)

, a venture capital firm, including four years as general partner, where he focused on investments in emerging healthcare companies. In 2015 Dr. Evnin co … as a member of our Board since August 2019. Since January 2019, he has served as a Managing Partner at Kensington-SV Global Innovations LP, a healthcare

1 May 23

7:35am

ONCR Oncorus, Inc.

Quarterly report

jurisdictions, there have been a number of legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay … for which we obtain marketing approval. We expect that current laws, as well as other healthcare reform measures that may be adopted in the future, may

4 Aug 22

4:52pm

ONCR Oncorus, Inc.

Quarterly report

to continue healthcare coverage under Section 4980B of the Internal Revenue Code of 1986, as amended (the “Code”) and the regulation thereunder

4 Aug 22

4:52pm

ONCR Oncorus, Inc.

Oncorus Reports Second Quarter 2022 Financial Results and Provides Business Updates

agreement with K2HV, a healthcare-focused specialty finance company, which provides Oncorus with up to $45 million available in multiple tranches upon

ONCR Oncorus, Inc.

Definitive proxy

, including four years as general partner, where he focused on investments in emerging healthcare companies. Dr. Evnin currently serves as Chief Executive … as a Managing Partner at Kensington-SV Global Innovations LP, a healthcare venture capital fund. Mr. Nam was instrumental in the formation of Kensington

13 May 22

7:42am

Oncorus Reports First Quarter 2022 Financial Results and Provides Business Updates

Annual report (amended)

29 Apr 22

4:06pm

Annual report (amended)

29 Apr 22

4:06pm

Entry into a Material Definitive Agreement

9 Mar 22

4:15pm

b9x4979mj712 xbc0eqr

9 Mar 22

4:15pm

h3ybkydghkgpnuss0lj

Entry into a Material Definitive Agreement

Definitive proxy

ias67352ni9sb 3g8

Prospectus supplement with pricing info

IPO registration

9 Feb 21

4:38pm

bgq xezwmely0umqr

IPO registration

9 Feb 21

4:38pm

IPO registration

9 Feb 21

4:38pm

Draft registration statement

Draft registration statement

Prev
1
2
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.